GLYCOPYRROLATE
NDC 13107-014, GLYCOPYRROLATE, tablet, from Aurolife Pharma LLC.
- Product NDC
- 13107-014
- Status
- Listed
- Labeler
- Aurolife Pharma LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202675
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/13107-014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCOPYRROLATE1 mg/1
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 13107-014-01 | 13107001401 | 100 TABLET in 1 BOTTLE (13107-014-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/677f8495-a870-45b6-bb65-75b449f040ceNADAC price for package 13107001401
GET /v1/drugs/nadac/13107001401
Use it
Look up 13107-014 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/13107-014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 13107-014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.